Professor Baruch Brenner is a senior clinical oncologist with extensive experience in the treatment of gastrointestinal cancers. His clinical work focuses on the comprehensive management of digestive system malignancies, including cancers of the stomach, intestines, liver, pancreas, and biliary tract.

In his practice, Professor Brenner emphasizes an individualized approach to each patient, along with multidisciplinary treatment planning involving specialists from different fields.

A significant part of his work involves complex clinical cases, as well as the development of new treatment strategies and participation in clinical research.

Clinical Expertise

Professor Baruch Brenner specializes in the treatment of:

Stomach cancer
Colorectal cancer
Pancreatic cancer
Liver cancer
Bile duct cancer
Gallbladder cancer
Digestive system tumors
Rare gastrointestinal tumors

In his clinical practice, he uses modern treatment approaches, including:

Systemic therapy
Targeted therapy
Immunotherapy
Personalized treatment
Clinical trials

Clinical Experience

Professor Baruch Brenner serves as Director of the Davidoff Cancer Center at Rabin Medical Center (Beilinson Hospital).

He also leads the gastrointestinal oncology program at the Davidoff Cancer Center.

Over the years, Professor Brenner has gained extensive experience in treating complex oncologic conditions and managing patients with rare tumor types.

Education and Training

Professor Baruch Brenner graduated from the Faculty of Medicine at Tel Aviv University.

He completed his oncology training at Beilinson Medical Center.

He also completed advanced fellowship training in gastrointestinal oncology at Memorial Sloan Kettering Cancer Center in New York, USA.

Academic Activity

Professor Baruch Brenner is a Professor of Oncology at the Faculty of Medicine, Tel Aviv University.

He is actively involved in training physicians and medical students, and in advancing clinical oncology in Israel.

Professional Memberships

Professor Baruch Brenner is a member of:

Israeli Society of Clinical Oncology and Radiotherapy
European Organisation for Research and Treatment of Cancer (EORTC)
Gastrointestinal Cancer Study Groups
Israeli Gastrointestinal Oncology Group
Professional gastro-oncology associations

He also serves on editorial boards of medical scientific journals.

Research Activity

Professor Brenner is actively involved in clinical and translational research in gastrointestinal oncology.
Clinical trials under his leadership are conducted at the Davidoff Cancer Center, including early-phase and advanced clinical studies.
He collaborates with international research organizations and biotechnology companies to develop new diagnostic and treatment approaches.
Scientific publications (PubMed)

Medical Approach

Professor Brenner follows a multidisciplinary approach to cancer treatment.

Treatment decisions are made together with surgeons, radiologists, gastroenterologists, and radiation oncologists.

This approach allows for selecting the most appropriate strategy for each patient.

Private Consultation with Professor Baruch Brenner

If you are seeking a second opinion, clarification of diagnosis, or discussion of treatment options, you may schedule a consultation with Professor Baruch Brenner.

📞 Call: +972-73-374-6844
📧 Email: [email protected]
💬 WhatsApp: +972-52-337-3108

Symptoms and Prevention of Colon Cancer - Prof. Baruch Brenner

Questions & Answers — Professor Baruch Brenner

1. When do patients usually come to see you?

Most often, patients come shortly after diagnosis. But many also reach out later — especially when a treatment plan has already been suggested and they want to take a moment to review everything more calmly.

Gastrointestinal cancers can be very different. Even with the same diagnosis, treatment approaches may vary.

So I usually start by reviewing pathology, imaging, and the medical history. Sometimes we don’t change anything. Sometimes we adjust the plan.

Both situations are completely normal.

2. Should I get a second opinion for stomach, colon, or pancreatic cancer?

I usually say — it’s a reasonable step. Especially when treatment is complex.

Many patients come simply to confirm they’re on the right path. Sometimes they are. Sometimes we explore additional options.

In oncology, there is rarely just one solution. That’s why second opinions are often part of the process.

3. How do you usually build a treatment plan?

I try not to rush decisions. First, it’s important to understand the full picture.

I review test results, talk with the patient, and sometimes consult surgeons or other specialists. With gastrointestinal cancers, treatment is often combined, so collaboration is essential.

Then we discuss possible options. I try to explain things clearly and without complicated terms.

4. Is chemotherapy always necessary?

No. And this is one of the most common questions.

Sometimes treatment starts with surgery. Sometimes with systemic therapy. In certain situations, we may even begin with observation.

There’s no universal answer. Every case is different.

5. Do you use new treatments and clinical trials?

Yes, when appropriate.

New therapies appear constantly, but not every new treatment is better than standard therapy. Sometimes it is. Sometimes it isn’t.

So we discuss options carefully and without pressure.

6. Can I start with an online consultation?

Yes. Many patients begin this way.

I usually ask patients to send medical records in advance. This helps me better understand the situation.

During the consultation, we discuss possible next steps. Often, we can already outline a plan.

7. What is most important when treating gastrointestinal cancers?

Probably the most important thing is not to rush decisions.

In most cases, there is time to carefully review options. Sometimes we involve surgeons, sometimes additional specialists.

I try to make sure patients understand what’s happening and what choices exist. That usually helps make decisions more comfortably.

There are no reviews yet. Be the first one to write one.